{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:07:29Z","timestamp":1791338849405,"version":"4.3.1"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"5","license":[{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL151651"],"award-info":[{"award-number":["R01HL151651"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL169156"],"award-info":[{"award-number":["R01HL169156"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015326","name":"Common Fund","doi-asserted-by":"publisher","award":["DP2HL147126"],"award-info":[{"award-number":["DP2HL147126"]}],"id":[{"id":"10.13039\/100015326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["RC2DK127989"],"award-info":[{"award-number":["RC2DK127989"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018138","name":"Kuni Foundation","doi-asserted-by":"publisher","award":["Discovery Grant"],"award-info":[{"award-number":["Discovery Grant"]}],"id":[{"id":"10.13039\/100018138","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008884","name":"Edward P. Evans Foundation","doi-asserted-by":"publisher","award":["Discovery Research Grant"],"award-info":[{"award-number":["Discovery Research Grant"]}],"id":[{"id":"10.13039\/100008884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["Scholar Award 1391-24"],"award-info":[{"award-number":["Scholar Award 1391-24"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Associazione Italiana per la Ricerca sul Cancro","award":["20125"],"award-info":[{"award-number":["20125"]}]},{"name":"Associazione Italiana per la Ricerca sul Cancro","award":["21267"],"award-info":[{"award-number":["21267"]}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C355\/A26819"],"award-info":[{"award-number":["C355\/A26819"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["22796"],"award-info":[{"award-number":["22796"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AIRC Postdoctoral Fellowship","award":["28390"],"award-info":[{"award-number":["28390"]}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA251138"],"award-info":[{"award-number":["R01CA251138"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL128239"],"award-info":[{"award-number":["R01HL128239"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["Blood Cancer Discoveries Grant"],"award-info":[{"award-number":["Blood Cancer Discoveries Grant"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["Scholar award 1344-18"],"award-info":[{"award-number":["Scholar award 1344-18"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014599","name":"Mark Foundation For Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA015704"],"award-info":[{"award-number":["P30CA015704"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001021","name":"Damon Runyon Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Splicing factor SF3B1 mutations are frequent somatic lesions in myeloid neoplasms that transform hematopoietic stem cells (HSCs) by inducing mis-splicing of target genes. However, the molecular and functional consequences of SF3B1 mutations in human HSCs and progenitors (HSPCs) remain unclear. Here, we identify the mis-splicing program in human HSPCs as a targetable vulnerability by precise gene editing of SF3B1 K700E mutations in primary CD34+ cells. Mutant SF3B1 induced pervasive mis-splicing and reduced expression of genes regulating mitosis and genome maintenance leading to altered differentiation, delayed G2\/M progression, and profound sensitivity to CHK1 inhibition (CHK1i). Mis-splicing or reduced expression of mitotic regulators BUBR1 and CDC27 delayed G2\/M transit and promoted CHK1i sensitivity. Clinical CHK1i prexasertib selectively targeted SF3B1-mutant immunophenotypic HSCs and abrogated engraftment in vivo. These findings identify mis-splicing of mitotic regulators in SF3B1-mutant HSPCs as a targetable vulnerability engaged by pharmacological CHK1 inhibition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>In this study, we engineer precise SF3B1 mutations in human HSPCs and identify CHK1 inhibition as a selective vulnerability promoted by mis-splicing of mitotic regulators. These findings uncover the mis-splicing program induced by mutant SF3B1 in human HSPCs and show that it can be therapeutically targeted by clinical CHK1 inhibitors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2643-3230.bcd-23-0230","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T10:39:06Z","timestamp":1718015946000},"page":"353-370","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Mis-splicing of Mitotic Regulators Sensitizes SF3B1-Mutated Human HSCs to CHK1 Inhibition"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1557-6577","authenticated-orcid":false,"given":"Martina","family":"Sarchi","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington. 1"},{"name":"Department of Molecular Medicine, University of Pavia, Pavia, Italy. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7859-7252","authenticated-orcid":false,"given":"Courtnee A.","family":"Clough","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington. 1"},{"name":"Molecular and Cellular Biology Program, University of Washington, Seattle, Washington. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0477-7365","authenticated-orcid":false,"given":"Edie I.","family":"Crosse","sequence":"additional","affiliation":[{"name":"Computational Biology Program, Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington. 4"},{"name":"Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington. 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3425-5081","authenticated-orcid":false,"given":"Jason","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1478-0964","authenticated-orcid":false,"given":"Laura D.","family":"Baquero Galvis","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington. 1"},{"name":"Molecular and Cellular Biology Program, University of Washington, Seattle, Washington. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1194-7421","authenticated-orcid":false,"given":"Nelli","family":"Aydinyan","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5559-1010","authenticated-orcid":false,"given":"Rachel","family":"Wellington","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington. 1"},{"name":"Molecular and Cellular Biology Program, University of Washington, Seattle, Washington. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1638-757X","authenticated-orcid":false,"given":"Feini","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Pavia, Pavia, Italy. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4039-3756","authenticated-orcid":false,"given":"Anna","family":"Gall\u00ec","sequence":"additional","affiliation":[{"name":"Department of Hematology, IRCCS S. Matteo Hospital Foundation, Pavia, Italy. 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5147-3866","authenticated-orcid":false,"given":"J. Philip","family":"Creamer","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4710-315X","authenticated-orcid":false,"given":"Sintra","family":"Stewart","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8046-1063","authenticated-orcid":false,"given":"Robert K.","family":"Bradley","sequence":"additional","affiliation":[{"name":"Computational Biology Program, Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington. 4"},{"name":"Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington. 5"},{"name":"Department of Genome Sciences, University of Washington, Seattle, Washington. 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1460-1611","authenticated-orcid":false,"given":"Luca","family":"Malcovati","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Pavia, Pavia, Italy. 2"},{"name":"Department of Hematology, IRCCS S. Matteo Hospital Foundation, Pavia, Italy. 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1328-364X","authenticated-orcid":false,"given":"Sergei","family":"Doulatov","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington. 1"},{"name":"Department of Genome Sciences, University of Washington, Seattle, Washington. 7"},{"name":"Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington. 8"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,6,7]]},"reference":[{"key":"2026041310174414100_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular international prognostic scoring system for myelodysplastic syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid"},{"key":"2026041310174414100_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood.2020004850","article-title":"SF3B1-mutant myelodysplastic syndrome as a distinct disease subtype\u2014a proposal of the International Working Group for the Prognosis of MDS","volume":"136","author":"Malcovati","year":"2020","journal-title":"Blood"},{"key":"2026041310174414100_bib3","doi-asserted-by":"crossref","first-page":"10004","DOI":"10.1038\/ncomms10004","article-title":"SF3B1 mutant MDS-initiating cells may arise from the haematopoietic stem cell compartment","volume":"6","author":"Mian","year":"2015","journal-title":"Nat Commun"},{"key":"2026041310174414100_bib4","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood-2017-03-776070","article-title":"SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells","volume":"130","author":"Mortera-Blanco","year":"2017","journal-title":"Blood"},{"key":"2026041310174414100_bib5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.celrep.2015.09.053","article-title":"Cancer-associated SF3B1 hotspot mutations induce cryptic 3\u2019 splice site selection through use of a different branch point","volume":"13","author":"Darman","year":"2015","journal-title":"Cell Rep"},{"key":"2026041310174414100_bib6","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1182\/blood.2020006868","article-title":"Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms","volume":"136","author":"Taylor","year":"2020","journal-title":"Blood"},{"key":"2026041310174414100_bib7","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1038\/leu.2016.149","article-title":"Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes","volume":"30","author":"Dolatshad","year":"2016","journal-title":"Leukemia"},{"key":"2026041310174414100_bib8","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood.2021012652","article-title":"Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome","volume":"139","author":"Clough","year":"2022","journal-title":"Blood"},{"key":"2026041310174414100_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aav5467","article-title":"A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome","volume":"11","author":"Bondu","year":"2019","journal-title":"Sci Transl Med"},{"key":"2026041310174414100_bib10","doi-asserted-by":"crossref","first-page":"eabn5135","DOI":"10.1126\/scitranslmed.abn5135","article-title":"Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1 mutated myelodysplasia","volume":"15","author":"Mian","year":"2023","journal-title":"Sci Transl Med"},{"key":"2026041310174414100_bib11","doi-asserted-by":"crossref","first-page":"e2111703119","DOI":"10.1073\/pnas.2111703119","article-title":"SF3B1 mutant-induced missplicing of MAP3K7 causes anemia in myelodysplastic syndromes","volume":"119","author":"Lieu","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026041310174414100_bib12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/ni.2615","article-title":"The transcriptional architecture of early human hematopoiesis identifies multilevel control of lymphoid commitment","volume":"14","author":"Laurenti","year":"2013","journal-title":"Nat Immunol"},{"key":"2026041310174414100_bib13","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1182\/bloodadvances.2021006325","article-title":"Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs","volume":"6","author":"Asimotis","year":"2021","journal-title":"Blood Adv"},{"key":"2026041310174414100_bib14","doi-asserted-by":"crossref","first-page":"815037","DOI":"10.3389\/fonc.2022.815037","article-title":"The coming of age of preclinical models of MDS","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"2026041310174414100_bib15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccell.2018.07.003","article-title":"Synthetic lethal and convergent biological effects of cancer-associated spliceosomal gene mutations","volume":"34","author":"Lee","year":"2018","journal-title":"Cancer Cell"},{"key":"2026041310174414100_bib16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ccell.2019.07.003","article-title":"Therapeutic targeting of RNA splicing catalysis through inhibition of protein arginine methylation","volume":"36","author":"Fong","year":"2019","journal-title":"Cancer Cell"},{"key":"2026041310174414100_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccell.2019.01.010","article-title":"Targeting an RNA-binding protein network in acute myeloid leukemia","volume":"35","author":"Wang","year":"2019","journal-title":"Cancer Cell"},{"key":"2026041310174414100_bib18","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1038\/s41375-021-01328-9","article-title":"Phase I first-in-human dose escalation study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms","volume":"35","author":"Steensma","year":"2021","journal-title":"Leukemia"},{"key":"2026041310174414100_bib19","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/s41588-023-01460-5","article-title":"SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response","volume":"55","author":"Bland","year":"2023","journal-title":"Nat Genet"},{"key":"2026041310174414100_bib20","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1158\/0008-5472.CAN-21-1843","article-title":"Cancer-associated SF3B1 mutations confer a BRCA-like cellular phenotype and synthetic lethality to PARP inhibitors","volume":"82","author":"Lappin","year":"2022","journal-title":"Cancer Res"},{"key":"2026041310174414100_bib21","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1038\/s41375-020-0753-9","article-title":"SF3B1 mutations induce R-loop accumulation and DNA damage in MDS and leukemia cells with therapeutic implications","volume":"34","author":"Singh","year":"2020","journal-title":"Leukemia"},{"key":"2026041310174414100_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/cancers9050041","article-title":"Targeting the ATR-CHK1 axis in cancer therapy","volume":"9","author":"Rundle","year":"2017","journal-title":"Cancers (Basel)"},{"key":"2026041310174414100_bib23","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1007\/s00018-013-1307-3","article-title":"Checkpoint kinase 1 in DNA damage response and cell cycle regulation","volume":"70","author":"Patil","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"2026041310174414100_bib24","doi-asserted-by":"crossref","first-page":"e163325","DOI":"10.1172\/JCI163325","article-title":"SF3B1 mutation and ATM deletion co-drive leukemogenesis via centromeric R-loop dysregulation","volume":"133","author":"Cusan","year":"2023","journal-title":"J Clin Invest"},{"key":"2026041310174414100_bib25","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.stem.2023.07.012","article-title":"Single-cell multi-omics defines the cell-type- specific impact of splicing aberrations in human hematopoietic clonal outgrowths","volume":"30","author":"Chamely","year":"2023","journal-title":"Cell Stem Cell"},{"key":"2026041310174414100_bib26","doi-asserted-by":"crossref","first-page":"10660","DOI":"10.1073\/pnas.0600447103","article-title":"Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1","volume":"103","author":"Vassilev","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026041310174414100_bib27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.devcel.2007.01.003","article-title":"Chk1 is required for spindle checkpoint function","volume":"12","author":"Zachos","year":"2007","journal-title":"Dev Cell"},{"key":"2026041310174414100_bib28","doi-asserted-by":"crossref","first-page":"12256","DOI":"10.1038\/ncomms12256","article-title":"Two functionally distinct kinetochore pools of BubR1 ensure accurate chromosome segregation","volume":"7","author":"Zhang","year":"2016","journal-title":"Nat Commun"},{"key":"2026041310174414100_bib29","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nrm1988","article-title":"The anaphase promoting complex\/cyclosome: a machine designed to destroy","volume":"7","author":"Peters","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026041310174414100_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","article-title":"Evolution of the cancer stem cell model","volume":"14","author":"Kreso","year":"2014","journal-title":"Cell Stem Cell"},{"key":"2026041310174414100_bib31","doi-asserted-by":"crossref","first-page":"20752","DOI":"10.1073\/pnas.0806917106","article-title":"Essential function of Chk1 can be uncoupled from DNA damage checkpoint and replication control","volume":"105","author":"Wilsker","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026041310174414100_bib32","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1073\/pnas.0806671106","article-title":"The DNA-damage effector checkpoint kinase 1 is essential for chromosome segregation and cytokinesis","volume":"106","author":"Peddibhotla","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026041310174414100_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.stem.2013.09.002","article-title":"Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via re-specification of lineage-restricted precursors","volume":"13","author":"Doulatov","year":"2013","journal-title":"Cell Stem Cell"},{"key":"2026041310174414100_bib34","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1158\/1078-0432.CCR-18-2728","article-title":"Broad spectrum activity of the checkpoint kinase 1 inhibitor prexasertib as a single agent or chemopotentiator across a range of preclinical pediatric tumor models","volume":"25","author":"Lowery","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2026041310174414100_bib35","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ccell.2016.08.006","article-title":"Physiologic expression of Sf3b1(K700E) causes impaired erythropoiesis, aberrant splicing, and sensitivity to therapeutic spliceosome modulation","volume":"30","author":"Obeng","year":"2016","journal-title":"Cancer Cell"},{"key":"2026041310174414100_bib36","doi-asserted-by":"crossref","first-page":"e27873","DOI":"10.7554\/eLife.27873","article-title":"Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR\/Cas9 and AAV6","volume":"6","author":"Bak","year":"2017","journal-title":"Elife"},{"key":"2026041310174414100_bib37","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1158\/0008-5472.CAN-17-3970","article-title":"Spliceosome mutations induce R loop-associated sensitivity to ATR inhibition in myelodysplastic syndromes","volume":"78","author":"Nguyen","year":"2018","journal-title":"Cancer Res"},{"key":"2026041310174414100_bib38","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1038\/s41467-024-46547-7","article-title":"Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutation","volume":"15","author":"Rombaut","year":"2024","journal-title":"Nat Commun"},{"key":"2026041310174414100_bib39","doi-asserted-by":"crossref","first-page":"216","DOI":"10.18632\/oncotarget.27400","article-title":"A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertib","volume":"11","author":"Blosser","year":"2020","journal-title":"Oncotarget"},{"key":"2026041310174414100_bib40","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/13543784.2020.1783238","article-title":"Prexasertib: an investigational checkpoint kinase inhibitor for the treatment of high-grade serous ovarian cancer","volume":"29","author":"Evangelisti","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"2026041310174414100_bib41","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nprot.2011.301","article-title":"AAV-mediated gene targeting methods for human cells","volume":"6","author":"Khan","year":"2011","journal-title":"Nat Protoc"},{"key":"2026041310174414100_bib42","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat Biotechnol"},{"key":"2026041310174414100_bib43","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2026041310174414100_bib44","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nmeth.1528","article-title":"Analysis and design of RNA sequencing experiments for identifying isoform regulation","volume":"7","author":"Katz","year":"2010","journal-title":"Nat Methods"},{"key":"2026041310174414100_bib45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"2026041310174414100_bib46","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/bioinformatics\/btp120","article-title":"TopHat: discovering splice junctions with RNA-Seq","volume":"25","author":"Trapnell","year":"2009","journal-title":"Bioinformatics"},{"key":"2026041310174414100_bib47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cogpsych.2009.12.001","article-title":"Bayesian hypothesis testing for psychologists: a tutorial on the Savage\u2013Dickey method","volume":"60","author":"Wagenmakers","year":"2010","journal-title":"Cogn Psychol"},{"key":"2026041310174414100_bib48","doi-asserted-by":"crossref","first-page":"14049","DOI":"10.1038\/ncomms14049","article-title":"Massively parallel digital transcriptional profiling of single cells","volume":"8","author":"Zheng","year":"2017","journal-title":"Nat Commun"},{"key":"2026041310174414100_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","article-title":"SCANPY: large-scale single-cell gene expression data analysis","volume":"19","author":"Wolf","year":"2018","journal-title":"Genome Biol"},{"key":"2026041310174414100_bib50","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-23-0230\/3461013\/bcd-23-0230.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-23-0230\/3485021\/bcd-23-0230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/5\/5\/353\/3489937\/bcd-23-0230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/5\/5\/353\/3489937\/bcd-23-0230.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:18:04Z","timestamp":1776089884000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/5\/5\/353\/747357\/Mis-splicing-of-Mitotic-Regulators-Sensitizes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,7]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,6,7]]},"published-print":{"date-parts":[[2024,9,3]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-23-0230","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2643-3230.26926123.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926123","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926132","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926129.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926126.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926132.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926129","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926126","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2643-3230.c.7429396.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.c.7429396","asserted-by":"object"}]},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"value":"2643-3230","type":"print"},{"value":"2643-3249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,7]]}}}